Therefore, in obese patients with increased expression of TLR4, the AT, which is already inflamed, makes a favorable environment for SARS-CoV-2-TLR4 interaction, exacerbating the pro-inflammatory cytokine production and increasing the severity of COVID-19 [160]. Here, TLR4 is linked to COVID-19.